COMMUNIQUÉS West-GlobeNewswire

-
Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025
22/04/2025 - 22:05 -
NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario
22/04/2025 - 22:05 -
Intuitive Announces First Quarter Earnings
22/04/2025 - 22:05 -
Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
22/04/2025 - 22:05 -
Sight Sciences Appoints Gary Burbach to its Board of Directors
22/04/2025 - 22:05 -
Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details
22/04/2025 - 22:30 -
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
22/04/2025 - 22:30 -
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
22/04/2025 - 22:30 -
Natural Mounjaro Recipe for Weight Loss: The Best OTC Tirzepatide Alternative, Slimjaro
22/04/2025 - 22:49 -
Clover Health Announces Changes to Board of Directors
22/04/2025 - 23:00 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22/04/2025 - 23:00 -
AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™
22/04/2025 - 17:18 -
Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
22/04/2025 - 17:49 -
EssilorLuxottica: Déclaration de transactions sur actions propres
22/04/2025 - 18:00 -
EssilorLuxottica: Disclosure of transactions in own shares
22/04/2025 - 18:00 -
Press release: Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025
22/04/2025 - 18:00 -
Elite Clinical Network and HealthyU Clinics Announce Strategic Partnership to Expand Access to Clinical Research
22/04/2025 - 18:28 -
MULTIMEDIA UPDATE: AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™
22/04/2025 - 19:50 -
Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids
22/04/2025 - 14:00
Pages